{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T08:42:11Z","timestamp":1781858531356,"version":"3.54.5"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2016,12,19]],"date-time":"2016-12-19T00:00:00Z","timestamp":1482105600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Cardiol"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1007\/s00246-016-1544-y","type":"journal-article","created":{"date-parts":[[2016,12,19]],"date-time":"2016-12-19T06:17:18Z","timestamp":1482128238000},"page":"525-530","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Nadolol for Treatment of Supraventricular Tachycardia in Infants and Young Children"],"prefix":"10.1007","volume":"38","author":[{"given":"Johannes C.","family":"von Alvensleben","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin J.","family":"LaPage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Regine","family":"Caruthers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Bradley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,12,19]]},"reference":[{"key":"1544_CR1","first-page":"167","volume":"2","author":"AS Nadas","year":"1952","unstructured":"Nadas AS, Daeschner CW, Blumenthal SL (1952) Paroxysmal tachycardia in infants and children; study of 41 cases. Pediatrics 2:167\u2013181","journal-title":"Pediatrics"},{"key":"1544_CR2","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/S0022-3476(81)80578-1","volume":"98","author":"A Garson Jr","year":"1981","unstructured":"Garson A Jr, Gillette PC, McNamara DG (1981) Supraventricular tachycardia in children: clinical features, response to treatment, and long-term follow-up in 217 patients. J Pediatr 98:875\u2013882","journal-title":"J Pediatr"},{"key":"1544_CR3","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/0735-1097(90)90555-4","volume":"15","author":"JC Perry","year":"1990","unstructured":"Perry JC, Garson A Jr (1990) Supraventricular tachycardia due to Wolff-Parkinson-White syndrome in children: early disappearance and late recurrence. J Am Coll Cardiol 15:1215","journal-title":"J Am Coll Cardiol"},{"key":"1544_CR4","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.amjcard.2013.05.035","volume":"112","author":"N Cain","year":"2013","unstructured":"Cain N, Irving C, Webber S, Beerman L, Arora G (2013) Natural history of Wolff-Parkinson-White syndrome diagnosed in childhood. Am J Cardiol 112:961\u2013965","journal-title":"Am J Cardiol"},{"key":"1544_CR5","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S0002-8703(96)90052-6","volume":"131","author":"SN Weindling","year":"1996","unstructured":"Weindling SN, Saul JP, Walsh EP (1996) Efficacy and risks of medical therapy for supraventricular tachycardia in neonates and infants. Am Heart J 131:66\u201372","journal-title":"Am Heart J"},{"key":"1544_CR6","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1111\/j.1540-8159.2011.03073.x","volume":"34","author":"JC Salerno","year":"2011","unstructured":"Salerno JC, Garrison MM, Larison C, Seslar SP (2011) Case fatality in children with supraventricular tachycardia in the United States. Pacing Clin Electrophysiol 34:832\u2013836","journal-title":"Pacing Clin Electrophysiol"},{"key":"1544_CR7","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1007\/s00246-002-1514-4","volume":"23","author":"S Sanatani","year":"2002","unstructured":"Sanatani S, Hamilton RM, Gross GJ (2002) Predictors of refractory tachycardia in infants with supraventricular tachycardia. Pediatr Cardiol 23:508\u2013512","journal-title":"Pediatr Cardiol"},{"key":"1544_CR8","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s00246-005-1126-x","volume":"27","author":"KK Wong","year":"2006","unstructured":"Wong KK, Potts JE, Etheridge SP, Sanatani S (2006) Medications used to manage supraventricular tachycardia in the infant: a north american survey. Pediatr Cardiol 27:199\u2013206","journal-title":"Pediatr Cardiol"},{"key":"1544_CR9","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0022-3476(78)80096-1","volume":"92","author":"P Gillette","year":"1978","unstructured":"Gillette P, Garson A Jr, Eterovic E, Neches W, Mullins C, McNamara DG (1978) Oral propranolol treatment in infants and children. J Pediatr 92:141\u2013144","journal-title":"J Pediatr"},{"key":"1544_CR10","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/S0149-2918(01)80109-0","volume":"23","author":"AJ Claxton","year":"2001","unstructured":"Claxton AJ, Cramer J, Pierce C (2001) A systematic review of the associations between dose regimens and medication compliance. Clin Ther 23:1296\u20131310","journal-title":"Clin Ther"},{"key":"1544_CR11","first-page":"22","volume":"16","author":"SD Saini","year":"2009","unstructured":"Saini SD, Schoenfield P, Kaulback K, Dubinsky MC (2009) Effect of medication dosing frequency on adherence in chronic diseases. Am J Manag Care 16:22\u201333","journal-title":"Am J Manag Care"},{"key":"1544_CR12","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1185\/03007995.2012.677419","volume":"28","author":"CI Coleman","year":"2012","unstructured":"Coleman CI, Roberts MS, Sobierai DM, Alam T, Kaur R (2012) Effect of dosing frequency on chronic cardiovascular disease medication adherence. Curr Med Res Opin 28:669\u2013680","journal-title":"Curr Med Res Opin"},{"key":"1544_CR13","first-page":"28","volume":"8","author":"U Borchard","year":"1990","unstructured":"Borchard U (1990) Pharmacokinetics of beta-adrenoceptor blocking agents: clinical significance of hepatic and\/or renal clearance. Clin Physiol Biochem 8:28\u201334","journal-title":"Clin Physiol Biochem"},{"key":"1544_CR14","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1002\/j.1552-4604.1992.tb03805.x","volume":"32","author":"AV Mehta","year":"1992","unstructured":"Mehta AV, Chidambaram B, Rice PJ (1992) Pharmacokinetics of nadolol in children with supraventricular tachycardia. J Clin Pharmacol 32:1023\u20131027","journal-title":"J Clin Pharmacol"},{"key":"1544_CR15","first-page":"737","volume":"88","author":"B Hayoun","year":"1995","unstructured":"Hayoun B, Lupoglazoff JM, Magnier S, Denjoy I, Casasoprana A (1995) Congenital long QT syndrome: an elective indication for beta blocker treatment. Apropos of 5 cases. Arch Mal Coeur Vaiss 88:737\u2013742","journal-title":"Arch Mal Coeur Vaiss"},{"key":"1544_CR16","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1161\/01.CIR.101.6.616","volume":"101","author":"AJ Moss","year":"2000","unstructured":"Moss AJ, Zareba W, Hall WJ et al (2000) Effectiveness and limitations of beta-blocker therapy in congenital long-QT syndrome. Circulation 101:616\u2013623","journal-title":"Circulation"},{"key":"1544_CR17","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/ncpgasthep0063","volume":"2","author":"J Bosch","year":"2005","unstructured":"Bosch J (2005) Is treatment with nadolol effective against the growth of small esophageal varices in patients with cirrhosis? Nat Clin Pract Gastroenterol Hepatol 2:18\u201319","journal-title":"Nat Clin Pract Gastroenterol Hepatol"},{"key":"1544_CR18","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1111\/j.1468-2982.2007.01367.x","volume":"27","author":"JC Garcia-Monco","year":"2007","unstructured":"Garcia-Monco JC, Foncea N, Bibao A, Ruiz de Velasco I, Gomez-Beldarrain M (2007) Impact of preventive therapy with nadolol and topiramate on the quality of life of migraine patients. Cephalalgia 27:920\u2013928","journal-title":"Cephalalgia"},{"key":"1544_CR19","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/j.1365-2133.2012.11131.x","volume":"168","author":"E Pope","year":"2013","unstructured":"Pope E, Chakkittakandiyil A, Lara-Corrales I, Maki E, Weinstein M (2013) Expanding the therapeutic repertoire of infantile haemangiomas: cohort\u2013blinded study of oral nadolol compared with propranolol. Br J Dermatol 168:222\u2013224","journal-title":"Br J Dermatol"},{"key":"1544_CR20","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1161\/CIRCEP.112.972620","volume":"5","author":"S Sanatani","year":"2012","unstructured":"Sanatani S, Potts JE, Reed JH et al (2012) The study of antiarrhythmic medications in infancy (SAMIS): a multicenter, randomized controlled trial comparing the efficacy and safety of diogxin versus propranolol for prophylaxis of supraventricular tachycardia in infant. Circ Arrhythm Electrophysiol 5:984\u2013991","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"1544_CR21","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/S0735-1097(10)80283-9","volume":"19","author":"AV Mehta","year":"1992","unstructured":"Mehta AV, Chidambaram B (1992) Efficacy and safety of intravenous and oral nadolol for supraventricular tachycardia in children. J Am Coll Cardiol 19:630\u2013635","journal-title":"J Am Coll Cardiol"},{"key":"1544_CR22","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1023\/A:1015954108734","volume":"7","author":"JJ Krukemeyer","year":"1990","unstructured":"Krukemeyer JJ, Boudoulas H, Binkley PF, Lima JJ (1990) Comparison of single dose and steady state nadolol plasma concentrations. Pharm Res 7:953\u2013956","journal-title":"Pharm Res"},{"key":"1544_CR23","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1002\/j.1552-4604.1977.tb04609.x","volume":"17","author":"J Dreyfus","year":"1977","unstructured":"Dreyfus J, Brannick LJ, Vukovich RA, Shaw JM, Willard DA (1977) Metabolic studies in patients with nadolol: oral and intravenous administration. J Clin Pharmacol 17:300\u2013307","journal-title":"J Clin Pharmacol"},{"issue":"Suppl 4","key":"1544_CR24","first-page":"22","volume":"52","author":"D Shand","year":"1976","unstructured":"Shand D (1976) Pharmakokinetics of propranolol: a review. Postgrad Med J 52(Suppl 4):22\u201325","journal-title":"Postgrad Med J"},{"key":"1544_CR25","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1023\/A:1016031313065","volume":"13","author":"RG Buice","year":"1996","unstructured":"Buice RG, Subramanian VS, Duchin KL, Uko-Nne S (1996) Bioequivalence of a highly variable drug: an experience with nadolol. Pharm Res 13:1109\u20131115","journal-title":"Pharm Res"},{"key":"1544_CR26","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.neulet.2011.04.076","volume":"498","author":"H Sun","year":"2011","unstructured":"Sun H, Mao Y, Wang J, Ma Y (2011) Effects of beta-adrenergic antagonist, propranolol on spatial memory and exploratory behavior in mice. Neurosci Lett 498:133\u2013137","journal-title":"Neurosci Lett"},{"key":"1544_CR27","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1016\/j.hrthm.2015.04.034","volume":"12","author":"JT Poterucha","year":"2015","unstructured":"Poterucha JT, Bos JM, Cannon BC, Ackerman MJ (2015) Frequency and severity of hypoglycemia in children with beta-blocker-treated long QT syndrome. Heart Rhythm 12:1815\u20131819","journal-title":"Heart Rhythm"},{"key":"1544_CR28","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1111\/j.0954-6820.1973.tb10625.x","volume":"193","author":"B Hesse","year":"1973","unstructured":"Hesse B, Pedersen JT (1973) Hypoglycaemia after propranol in children. Acta Med Scan 193:551\u2013552","journal-title":"Acta Med Scan"},{"key":"1544_CR29","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1001\/archdermatol.2010.158","volume":"146","author":"KE Holland","year":"2010","unstructured":"Holland KE, Frieden IJ, Frommelt PC, Mancini AJ, Wyatt D, Drolet BA (2010) Hypoglycemia in children taking propranol for the treatment of infantile hemangioma. Arch Dermatol 146:775\u2013778","journal-title":"Arch Dermatol"}],"container-title":["Pediatric Cardiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00246-016-1544-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00246-016-1544-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00246-016-1544-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,25]],"date-time":"2017-06-25T06:13:02Z","timestamp":1498371182000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00246-016-1544-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12,19]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["1544"],"URL":"https:\/\/doi.org\/10.1007\/s00246-016-1544-y","relation":{},"ISSN":["0172-0643","1432-1971"],"issn-type":[{"value":"0172-0643","type":"print"},{"value":"1432-1971","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12,19]]}}}